Molecular and functional characteristics of a protective human monoclonal antibody to serotype 8 Streptococcus pneumoniae capsular polysaccharide

被引:34
作者
Zhong, Z
Burns, T
Chang, Q
Carroll, M
Pirofski, L
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Div Infect Dis, Dept Med, Bronx, NY 10461 USA
[2] Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
[3] Harvard Univ, Sch Med, Dept Pathol, Ctr Blood Res, Boston, MA 02115 USA
关键词
D O I
10.1128/IAI.67.8.4119-4127.1999
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The structural characteristics and biological activity of human antibodies that are reactive with the capsular polysaccharides of most serotypes of Streptococcus pneumoniae, including serotype 8, are unknown. This paper describes the generation, molecular structure, and protective efficacy of a human monoclonal antibody (MAb) reactive with the capsular polysaccharide of serotype 8 Streptococcus pneumoniae. We generated the immunoglobulin M(kappa) [IgM(kappa)] MAb D11 by Epstein-Barr virus transformation of peripheral lymphocytes from a Pneumovax recipient. Nucleic acid sequence analysis revealed that MAb D11 uses V3-15/V(H)3 and A20/V-kappa gene segments with evidence of somatic mutation. In vitro studies revealed MAb D11-dependent complement deposition on the capsule of serotype 8 organisms via either the classical or the alternative complement pathway. In vivo, MAb D11 prolonged the survival of both normal and C4-deficient mice with lethal serotype 8 S. pneumoniae infection. Our findings demonstrate that a serotype-specific human IgM with certain structural and functional characteristics was protective in mice lacking a functional classical complement pathway and show that alternative complement pathway activation is an important determinant of pneumococcal protection.
引用
收藏
页码:4119 / 4127
页数:9
相关论文
共 56 条
[1]   VIRULENCE OF STREPTOCOCCUS-PNEUMONIAE IN MICE - A STANDARDIZED METHOD FOR PREPARATION AND FROZEN STORAGE OF THE EXPERIMENTAL BACTERIAL INOCULUM [J].
AABERGE, IS ;
ENG, J ;
LERMARK, G ;
LOVIK, M .
MICROBIAL PATHOGENESIS, 1995, 18 (02) :141-152
[2]   Enhancement of Streptococcus pneumoniae serotype 6B infection in mice after passive immunization with human serum [J].
Aaberge, IS ;
Hvalbye, B ;
Lovik, M .
MICROBIAL PATHOGENESIS, 1996, 21 (02) :125-137
[3]   Human antibodies elicited by a pneumococcal vaccine express idiotypic determinants indicative of VH3 gene segment usage [J].
Abadi, J ;
Friedman, J ;
Mageed, RA ;
Jefferis, R ;
Rodriguez-Barradas, MC ;
Pirofski, LA .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (03) :707-716
[4]  
ADDERSON EE, 1993, J IMMUNOL, V151, P800
[5]   Gapped BLAST and PSI-BLAST: a new generation of protein database search programs [J].
Altschul, SF ;
Madden, TL ;
Schaffer, AA ;
Zhang, JH ;
Zhang, Z ;
Miller, W ;
Lipman, DJ .
NUCLEIC ACIDS RESEARCH, 1997, 25 (17) :3389-3402
[6]   Epidemiological features of and risk factors for infection by Streptococcus pneumoniae strains with diminished susceptibility to penicillin: Findings of a French survey [J].
Bedos, JP ;
Chevret, S ;
Chastang, C ;
Geslin, P ;
Regnier, B .
CLINICAL INFECTIOUS DISEASES, 1996, 22 (01) :63-72
[7]   DIRECT EVIDENCE THAT DECREASED SERUM OPSONIZATION OF STREPTOCOCCUS-PNEUMONIAE VIA THE ALTERNATIVE COMPLEMENT PATHWAY IN SICKLE-CELL DISEASE IS RELATED TO ANTIBODY DEFICIENCY [J].
BJORNSON, AB ;
LOBEL, JS .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (02) :388-398
[8]   LACK OF A REQUIREMENT FOR THE FC-REGION OF IGG IN RESTORING PNEUMOCOCCAL OPSONIZATION VIA THE ALTERNATIVE COMPLEMENT PATHWAY IN SICKLE-CELL DISEASE [J].
BJORNSON, AB ;
LOBEL, JS .
JOURNAL OF INFECTIOUS DISEASES, 1986, 154 (05) :760-769
[9]   A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection [J].
Boes, M ;
Prodeus, AP ;
Schmidt, T ;
Carroll, MC ;
Chen, JZ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (12) :2381-2386
[10]   Analysis of the human V-H gene repertoire - Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM(+) and CD5(-)/IgM(+) B cells [J].
Brezinschek, HP ;
Foster, SJ ;
Brezinschek, RI ;
Dorner, T ;
DomiatiSaad, R ;
Lipsky, PE .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (10) :2488-2501